Protagonist Therapeutics, Inc. i-capital capital
Yonke imihla, sirekhoda utshintsho kwi-Protagonist Therapeutics, Inc. capitalization. Iwebhusayithi yethu ithatha ulwazi lwe-Protagonist Therapeutics, Inc. eyongameleyo yanamhlanje kwimithombo evulekile. Protagonist Therapeutics, Inc. capitalization yanamhlanje kwiwebhusayithi yethu ukuze ibhekiswe kuyo. Ixabiso layo yonke i Protagonist Therapeutics, Inc. izitokhwe ezikhutshiweyo (Protagonist Therapeutics, Inc. cap cap) yehle nge $ -57 963 520.
Protagonist Therapeutics, Inc. ivolumu yezorhwebo
Protagonist Therapeutics, Inc. iivolumu zorhwebo namhlanje zifikelele kwi $ 128 830. Protagonist Therapeutics, Inc. ithengiswa kwiiwebhusayithi ezahlukeneyo zorhwebo. Protagonist Therapeutics, Inc. ukurhweba kwi-intanethi okuthengiswa kwiimarike ezininzi zesitokhwe, sibonisa umthamo opheleleyo Protagonist Therapeutics, Inc. ngosuku. Protagonist Therapeutics, Inc. capitalization yehla ngosuku kwiidola zaseMelika.
|
Protagonist Therapeutics, Inc. istatshi yekhredithi yemakethe
Protagonist Therapeutics, Inc. eyinkunzi yentengiso kwigrafu ngeminyaka. Kwiveki yonke, Protagonist Therapeutics, Inc. capitalisation itshintshwe ngu 0.69%. Protagonist Therapeutics, Inc. utshintsho lwemali enkulu enyakeni 0%. Namhlanje, Protagonist Therapeutics, Inc. capitalization ilingane 1 317 965 184 iidola zaseMelika.
Iveki | Inyanga | iinyanga 3 | Unyaka | Iminyaka emithathu |
Protagonist Therapeutics, Inc. imbali yenkxaso-mali
Umhla |
Ixabiso
Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
|
---|---|
04/05/2023 | 1 317 965 184 $ |
03/05/2023 | 1 375 928 704 $ |
02/05/2023 | 1 306 428 800 $ |
01/05/2023 | 1 325 280 896 $ |
28/04/2023 | 1 313 580 416 $ |
27/04/2023 | 1 294 892 416 $ |
26/04/2023 | 1 308 961 152 $ |
Protagonist Therapeutics, Inc. isatifiketi somqulu
Iveki | Inyanga | iinyanga 3 | Unyaka | Iminyaka emithathu |
Protagonist Therapeutics, Inc. idatha yembali yevolumu
Umhla |
Umqulu (24h)
Ixabiso lezorhwebo leProtagonist Therapeutics, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-PTGX ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
|
---|---|
04/05/2023 | 128 830 $ |
03/05/2023 | 1 306 201 $ |
02/05/2023 | 704 792 $ |
01/05/2023 | 701 288 $ |
28/04/2023 | 326 821 $ |
27/04/2023 | 130 124 $ |
26/04/2023 | 608 967 $ |
Protagonist Therapeutics, Inc. capitalisation yimali eyi- $ 1 317 965 184 kwi 04/05/2023. Protagonist Therapeutics, Inc. i-capitalisation yentengiso kwi 03/05/2023 ilingana ne 1 375 928 704 iidola zaseMelika. Protagonist Therapeutics, Inc. capitalisation yimali eyi- $ 1 306 428 800 kwi 02/05/2023. 01/05/2023 Protagonist Therapeutics, Inc. capitalisation ilingana 1 325 280 896 iidola zaseMelika.
Iimali yentengiso enkulu ye Protagonist Therapeutics, Inc. kwi 28/04/2023 ifikelele kuthi 1 313 580 416 iidola zaseMelika. Vuliwe 27/04/2023, Protagonist Therapeutics, Inc. capitalisation yayiyi- $ 1 294 892 416. 26/04/2023 Protagonist Therapeutics, Inc. capitalization ilingane 1 308 961 152 iidola zaseMelika.
Inkcitho ye-Protagonist Therapeutics, Inc. namhlanje ngu-1 317 965 184 $. Iimali zentengiso ye-Protagonist Therapeutics, Inc. ishintshile -4.213% xa kuthelekiswa nezolo. Imali yokuthengisa ye PTGX izabelo ze Protagonist Therapeutics, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-128 830 $. Ixabiso lokuthengiswa kwezabelo ze Protagonist Therapeutics, Inc. latshintshile kwi--90.137% xa kuthelekiswa nosuku lwangaphambili lworhwebo.